Literature DB >> 4005814

Rhabdomyosarcoma of the biliary tree in childhood. A report from the Intergroup Rhabdomyosarcoma Study.

F B Ruymann, R B Raney, W M Crist, W Lawrence, R D Lindberg, E H Soule.   

Abstract

Ten cases of rhabdomyosarcoma of the biliary tree (RMS/BT) in children are reported in this review of the Intergroup Rhabdomyosarcoma Study (IRS) I and II. RMS/BT constitutes 0.8% of evaluable tumors on IRS I and II. Intermittent obstructive jaundice with or without abdominal distention, fever, and loss of appetite is the typical presentation. Attribution of these symptoms to hepatitis commonly delayed definitive treatment. Demonstration of a mass in the porta hepatitis by ultrasound led quickly to surgical consultation and an exploratory laparotomy. Intraoperative cholangiography was a valuable technique in establishing the level of biliary tree obstruction and verifying a functioning drainage procedure. Resection of the mass with only microscopic or minimal gross residual disease was possible at the initial surgery in six of the ten patients. Included in this group are all four of the surviving patients. The continuity of bile flow was usually maintained by variations of a Roux-en-Y jejunostomy. Histology was embryonal RMS with some botryoid elements. Consultation with a surgical pathologist during the course of the surgery was of invaluable assistance. Multi-drug chemotherapy and radiotherapy consistent with the IRS protocols were given postoperatively. A second-look surgery was useful in evaluating residual or recurrent disease. Four patients are surviving free of disease at 6 months, 3, 6 1/4, and 6 1/2 years from diagnosis, respectively. This review demonstrates that a multidisciplinary approach in RMS/BT can lead to long-term survival.

Entities:  

Mesh:

Year:  1985        PMID: 4005814     DOI: 10.1002/1097-0142(19850801)56:3<575::aid-cncr2820560326>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

1.  Sarcoma botryoides of the common bile duct: preoperative diagnosis by coronal CT and PTC.

Authors:  A Verstandig; J Bar-Ziv; K I Abu-Dalu; E Granot; M Schiller
Journal:  Pediatr Radiol       Date:  1991

Review 2.  The changing face of hepatic resection.

Authors:  S Iwatsuki; D G Sheahan; T E Starzl
Journal:  Curr Probl Surg       Date:  1989-05       Impact factor: 1.909

3.  Rhabdomyosarcoma of the biliary tree.

Authors:  N Sanz; L de Mingo; F Flórez; V Rollán
Journal:  Pediatr Surg Int       Date:  1997-02       Impact factor: 1.827

4.  Embryonal rhabdomyosarcoma of the common bile duct.

Authors:  Alpana Prasad; Rajiv Chadha; S Roy Choudhury
Journal:  Indian J Pediatr       Date:  2003-01       Impact factor: 1.967

5.  [Primary pleomorphic rhabdomyosarcoma of the liver].

Authors:  U Meyer-Pannwitt; K Kummerfeldt; C E Broelsch
Journal:  Langenbecks Arch Chir       Date:  1996

6.  Botryoid rhabdomyosarcoma of common bile duct.

Authors:  Kiran Aggarwal; Sangeeta Pahuja; Rajeev Chadha
Journal:  Indian J Pediatr       Date:  2004-04       Impact factor: 1.967

Review 7.  Adult rhabdomyosarcoma of the gall bladder: case report and review of published works.

Authors:  T M al-Jaberi; N al-Masri; A Tbukhi
Journal:  Gut       Date:  1994-06       Impact factor: 23.059

8.  Malignant liver tumors in South African children: a national audit.

Authors:  S W Moore; A Davidson; G P Hadley; M Kruger; J Poole; D Stones; L Wainwright; G Wessels
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352

Review 9.  Imaging features of rare mesenychmal liver tumours: beyond haemangiomas.

Authors:  Rajesh Thampy; Khaled M Elsayes; Christine O Menias; Perry J Pickhardt; Hyunseon C Kang; Sandeep P Deshmukh; Kareem Ahmed; Brinda Rao Korivi
Journal:  Br J Radiol       Date:  2017-08-02       Impact factor: 3.039

10.  Suboptimal outcome for patients with biliary rhabdomyosarcoma treated on low-risk clinical trials: A report from the Children's Oncology Group.

Authors:  Jamie M Aye; Wei Xue; Joshua D Palmer; David O Walterhouse; Michael A Arnold; Todd E Heaton; Rajkumar Venkatramani
Journal:  Pediatr Blood Cancer       Date:  2021-01-26       Impact factor: 3.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.